Information Library

Results for: Get to market faster - Market Access

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Franchise Influence and Leverage Mapping

    Brochure — November 10, 2011
    In this industry it’s not just whom you know, but who knows you and how far their sphere of influence reaches.

  • How Informative is Your Segmentation?

    Hear from the Experts — September 15, 2011
    Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011.

  • The Use of Large Simple Trials

    Presentation — February 25, 2011
    Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data.

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • Oncology Drug Development and Value-Based Medicine

    White Paper — November 5, 2010
    This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices.

  • A Blueprint for Clinical / Commercial Convergence

    White Paper — August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • Defining Value

    Brochure — June 8, 2010
    Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts.

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • Orphan Drugs in the U.S.

    Presentation — June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.”

  • Poised for success

    Presentation — June 16, 2009
    Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility

Page 1 of 2 (14 results)

Subscribe to Email Based on Your Interests

Set preferences